---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-013896"
form_type: "8-K"
ticker: "XFOR"
cik: "0001501697"
company_name: "X4 Pharmaceuticals, Inc"
filed_at: "2024-04-01T23:59:59+00:00"
generated_at: "2026-06-04T04:32:35.758234+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# X4 Pharmaceuticals posts updated corporate presentation on website

## Summary
- X4 Pharmaceuticals filed an 8-K on April 1, 2024, announcing an updated corporate presentation.
- The presentation is available on the Investors section of the company's website at www.x4pharma.com.
- No financial results, material agreements, or other major events were disclosed in the filing.

## SEC filing metadata
- accession: 0001628280-24-013896
- form_type: 8-K
- ticker: XFOR
- cik: 0001501697
- company_name: X4 Pharmaceuticals, Inc
- filed_at: 2024-04-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1501697/000162828024013896/0001628280-24-013896-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1501697/000162828024013896/xfor-20240401.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-013896
- JSON: https://secwatch.observer/filing/0001628280-24-013896.json
- Plain text: https://secwatch.observer/filing/0001628280-24-013896.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.